Roche turns to Dualitas to find new bispecific approaches for immunology

Roche is turning up the heat on its hunt for next-generation bispecific antibodies in a deal that will involve screening 300,000 new combinations for inflammatory and immunology conditions. The Swiss pharma is delivering $36.5 million ...